CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2020; 30(03): 304-318
DOI: 10.4103/ijri.IJRI_279_20
Gynecology Imaging

Prospective revalidation of IOTA “two-step”, “alternative two-step” and “three-step” strategies for characterization of adnexal masses – An Indian study focussing the radiology context

Shabnam Bhandari Grover
Department of Radiology and Imaging, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Sayantan Patra
Department of Radiology and Imaging, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
,
Hemal Grover
Department of Radiology, Icahn School of Medicine at Mount Sinai West, New York, USA
,
Pratima Mittal
Department of Gynecology and Obstetrics, Vardhman Mahavir Medical College and Safdarjung Hospital
,
Geetika Khanna
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Objectives: The purpose of this study was to revalidate the diagnostic performance of IOTA “two step” (Simple Descriptors and Simple Rules), “ alternative two step” (Simple Rules Risk Calculation tool / SRrisk score), and three step (two step with subjective assessment) strategies, for characterization of adnexal masses as benign or malignant, using histopathology as gold standard. Materials and Methods: This prospective, study comprised of 100 patients with newly diagnosed adnexal masses, who underwent ultrasound evaluation first by a level I and then by a level III investigator (EFSUMB criteria). Initially, the level I investigator evaluated each adnexal mass, applying IOTA “two-step” strategy and simultaneously assigned a risk category, by applying the simple rules risk score (SRrisk score ) or performing the “alternative two step” strategy. Subsequently the inconclusive masses were evaluated by the level III investigator using “real time subjective assessment”, thereby performing the third step. Following histopathology diagnosis, the performance of each strategy was evaluated using diagnostic tests. Results: The sensitivity, specificity, PPV, NPV, and diagnostic accuracy of “two-step” strategy were 87.5%, 79.2%, 89.4%, 76%, and 84.7%, respectively; those of “alternative two-step” strategy were 91.5%, 75.6%, 84.4%, 86.1% and 88%; and those of “three-step” strategy were 98.2%, 93.3%, 94.7%, 97.7% and 96%, respectively. Conclusion: All IOTA strategies showed good diagnostic performance for characterization of adnexal masses and the “three-step” strategy performed best. We believe this is the first ever prospective re-validation and comparative evaluation of all three IOTA strategies by Indian Radiologists. Since ultrasound is the primary modality for evaluation of adnexal masses, based on the good results of our study, a recommendation for henceforth standard application, of the three-step IOTA strategy in routine Radiology practice appears justified. Although, IOTA strategies been proposed and validated mainly by Gynaecologists and Oncology surgeons, based on the results of our study, this paradigm can now be made to shift back to the arena of Radiology and Radiologists, the imaging experts.



Publication History

Received: 20 August 2020

Accepted: 17 August 2020

Article published online:
19 July 2021

© 2020. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Timmerman D, Van Calster B, Testa A, Savelli L, Fischerova D, Froyman W. et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 2016; 214: 424-37
  • 2 Sayasneh A, Kaijser J, Preisler J, Johnson S, Stalder C, Husicka R. et al. A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses. Gynecol Oncol 2013; 130: 140-6
  • 3 Timmerman D, Valentin L, Bourne T, Collins W, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: A consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 2000; 16: 500-5
  • 4 Timmerman D, Testa A, Bourne T, Ferrazzi E, Ameye L, Konstantinovic M. et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: A multicenter study by the international ovarian tumor analysis group. J Clin Oncol 2005; 23: 8794-801
  • 5 Timmerman D, Van Calster B, Jurkovic D, Valentin L, Testa A, Bernard J. et al. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors. J Clin Oncol 2007; 25: 4194-200
  • 6 Timmerman D, Testa A, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C. et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol 2008; 31: 681-90
  • 7 Timmerman D, Van Calster B, Testa A, Guerriero S, Fischerova D, Lissoni A. et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: A temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol 2010; 36: 226-34
  • 8 Timmerman D, Ameye L, Fischerova D, Epstein E, Melis G, Guerriero S. et al. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: Prospective validation by IOTA group. BMJ 2010; 341: c6839
  • 9 Ameye L, Timmerman D, Valentin L, Paladini D, Zhang J, Van Holsbeke C. et al. Clinically oriented three-step strategy for assessment of adnexal pathology. Ultrasound Obstet Gynecol 2012; 40: 582-91
  • 10 Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I. et al. Improving strategies for diagnosing ovarian cancer: A summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound Obstet Gynecol 2012; 41: 9-20
  • 11 Testa A, Kaijser J, Wynants L, Fischerova D, Van Holsbeke C, Franchi D. et al. Strategies to diagnose ovarian cancer: New evidence from phase 3 of the multicentre international IOTA study. Br J Cancer 2014; 111: 680-8
  • 12 Alcázar JL. Ultrasound-based IOTA simple rules allow accurate malignancy risk estimation for adnexal masses. BMJ Evid Based Med 2016; 21: 197
  • 13 Hidalgo J, Ros F, Aubá M, Errasti T, Olartecoechea B, Ruiz-Zambrana Á. et al. Prospective external validation of IOTA three - step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two - step strategy using simple-rules risk. Ultrasound Obstet Gynecol 2019; 53: 693-700
  • 14 Alcázar J, Pascual M, Graupera B, Aubá M, Errasti T, Olartecoechea B. et al. External validation of IOTA simple descriptors and simple rules for classifying adnexal masses. Ultrasound Obstet Gynecol 2016; 48: 397-402
  • 15 Garg S. Evaluation of IOTA simple ultrasound rules to distinguish benign and malignant ovarian tumours. J Clin Diagn Res 2017; 11: TC06-9
  • 16 Shetty J, Saradha A, Pandey D, Bhat R, Kumar P, Bharatnur S. IOTA simple ultrasound rules for triage of adnexal mass: Experience from South India. J Obstet Gynecol India 2019; 69: 356-62
  • 17 Andreotti R, Timmerman D, Strachowski L, Froyman W, Benacerraf B, Bennett G. et al. O-RADS US risk stratification and management system: A consensus guideline from the ACR ovarian-adnexal reporting and data system committee. Radiology 2020; 294: 168-85
  • 18 [Internet]. Efsumb.org. 2020. Available from: http://www.efsumb.org/guidelines/2009-04-14apx1.pdf. [Last cited on 2020 Apr 19]
  • 19 Bourne T, Valentin L, Timmerman D. A multicentre study to examine the short and long term outcomes of the conservative management of benign-looking adnexal masses and the pre-operative characterisation of ovarian tumours [Internet]. Clinical trials.gov 2020. Available from: https://clinicaltrials.gov/ProvidedDocs/32/NCT01698632/Prot_000.pdf. [Last cited on 2020 Apr 19]
  • 20 IOTA. Simple Rules and SR risk calculator to diagnose ovarian cancer. Iota Group; [Internet]. Iotagroup.org. 2020. Available from: https://www.iotagroup.org/iota-models-software/iota-simple-rules-and-srrisk-calculator-diagnose-ovarian-cancer. [Last cited on 2020 Apr 19]
  • 21 Pineda L, Salcedo E, Vilhena C, Juez L, Alcázar J. Interobserver agreement in assigning IOTA color score to adnexal masses using three-dimensional volumes or digital videoclips: Potential implications for training. Ultrasound Obstet Gynecol 2014; 44: 361-4
  • 22 Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I. et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound in Obstetrics & Gynecology 2012; 41 (01) 9-20
  • 23 Kaijser J. Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies. Facts Views Vis Obgyn 2015; 7 (01) 42-59
  • 24 Sassone AM, Timor-Tritsch IE, Artnew A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol 1991; 78: 70-6
  • 25 Valentin L, Sladkevicius P, Marsàl K. Limited contribution of Doppler velocimetry to the differential diagnosis of extrauterine pelvic tumors. Obstet Gynecol 1994; 83: 425-33
  • 26 Valentin L. Gray scale sonography, subjective evaluation of the color Doppler image and measurement of blood flow velocity for distinguishing benign and malignant tumors of suspected adnexal origin. Eur J Obstet Gynecol Reprod Biol 1997; 72: 63-72
  • 27 Alcazar J, Pascual M, Olartecoechea B, Aubá M, Graupera B, Hereter L. et al. OC14.08: IOTA simple rules for discriminating between benign and malignant adnexal masses: A prospective external validation. Ultrasound Obstet Gynecol 2013; 42 (01) 30-30
  • 28 Nunes N, Ambler G, Foo X, Naftalin J, Widschwendter M, Jurkovic D. Use of IOTA simple rules for diagnosis of ovarian cancer: Meta-analysis. Ultrasound Obstet Gynecol 2014; 44: 503-14
  • 29 Patel-Lippmann K, Sadowski E, Robbins J, Paroder V, Barroilhet L, Maddox E. et al. Comparison of International ovarian tumor analysis simple rules to society of radiologists in ultrasound guidelines for detection of malignancy in adnexal cysts. AJR 2020; 214: 694-700
  • 30 Meys E, Kaijser J, Kruitwagen R, Slangen B, Van Calster B, Aertgeerts B. et al. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis. Eur J Cancer 2016; 58: 17-29
  • 31 Thomassin-Naggara I, Aubert E, Rockall A, Jalaguier-Coudray A, Rouzier R, Daraï E. et al. Adnexal masses: Development and preliminary validation of an mr imaging scoring system. Radiology 2013; 267: 432-43
  • 32 Pereira PN, Sarian LO, Yoshida A, Araújo KG, Barros RH, Baião AC. et al. Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses. Diagn Interv Radiol 2018; 24: 63-71
  • 33 Pereira P, Sarian L, Yoshida A, Araújo K, Silva A, de Oliveira Barros R. et al. Improving the performance of IOTA simple rules: Sonographic assessment of adnexal masses with resource-effective use of a magnetic resonance scoring (ADNEX MR scoring system). Abdom Radiol 2020; 45: 3218-29